• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ALTRUA 60; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ALTRUA 60; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT) Back to Search Results
Model Number S606
Device Problem Premature Discharge of Battery (1057)
Patient Problems Atrial Flutter (1730); Death (1802)
Event Date 04/23/2020
Event Type  Death  
Manufacturer Narrative
Following return and completion of laboratory analysis, this event will be further updated.
 
Event Description
It was reported that the patient with this pacemaker device passed away from unreported causes.The local field representative was contacted to assist with a post mortem interrogation, deactivation and return of the device for episode review and a longevity evaluation.It was stated the device had been implanted over ten years and had been programmed in dddr and later vvir modes, due to atrial flutter.The patient was reportedly 100 percent ventricular paced with a stable remaining battery life at 2 years.The patient was intended to be seen for another follow-up in (b)(6) of 2020 however the appointment cancelled due to covid concerns and the rescheduled (b)(6) follow-up was unattended by the patient.The post mortem interrogation confirmed the end of life (eol) battery status had been set in april 2020 with a magnet rate of 85 and vvi pacing at 50.The patient passed away in (b)(6) 2020.The physician has not correlated the patients death directly to the depleted battery but has requested a longevity review for performance indication.
 
Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.The associated investigation determined that battery status indicators were different than expected based on information provided to boston scientific.Factors influencing the estimated longevity remaining calculation include pacing rate, amplitude, pulse-width and lead impedance.Any changes in these factors will impact the battery consumption calculation and therefore the remaining longevity estimate.Please refer to the description for more information regarding the specific circumstances of this event.Please note this pacemakers battery was designed to estimate remaining longevity and trigger corresponding device replacement indicators based on the pacing capacitor charge time, which progressively increases as the battery depletes.These pacemakers were not designed with an ability to calculate remaining longevity for every possible current drain, which may cause replacement indicators to trigger earlier than what was previously estimated; however, it does not negatively impact the use, operation, safety, or performance of the device.
 
Event Description
It was reported that the patient with this pacemaker device passed away from unreported causes.The local field representative was contacted to assist with a post mortem interrogation, deactivation and return of the device for episode review and a longevity evaluation.It was stated the device had been implanted over ten years and had been programmed in dddr and later vvir modes, due to atrial flutter.The patient was reportedly 100 percent ventricular paced with a stable remaining battery life at 2 years.The patient was intended to be seen for another follow-up in (b)(6) 2020 however the appointment cancelled due to covid concerns and the rescheduled august follow-up was unattended by the patient.The post mortem interrogation confirmed the end of life (eol) battery status had been set in (b)(6) 2020 with a magnet rate of 85 and vvi pacing at 50.The patient passed away in (b)(6) 2020.The physician has not correlated the patients death directly to the depleted battery but has requested a longevity review for performance indication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALTRUA 60
Type of Device
IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key10705214
MDR Text Key212103781
Report Number2124215-2020-21214
Device Sequence Number1
Product Code LWP
UDI-Device Identifier00802526484490
UDI-Public00802526484490
Combination Product (y/n)N
PMA/PMN Number
N970003/S106
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 11/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/16/2011
Device Model NumberS606
Device Catalogue NumberS606
Device Lot Number120284
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/24/2020
Initial Date FDA Received10/20/2020
Supplement Dates Manufacturer Received10/30/2020
Supplement Dates FDA Received11/23/2020
Patient Sequence Number1
Patient Outcome(s) Death;
-
-